Drug recall · July 3, 2019
Pramipexole Dihydrochloride Tablets recall
Why: GMP Deviations; possible cross contamination of product due to cleaning procedure failure.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Pramipexole Dihydrochloride Tablets, 1.0 mg, 30 Tablets (6 tablets per blister card), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217 NDC Blister Card: 68084-982-95; NDC Carton: 68084-982-25
- Lots / codes
Lot, expiry: Lot 176179, exp 05/31/2019; Lot 176616, exp 07/31/2019; Lot 178562, exp 09/30/2019; Lot 179947, exp 12/31/2019; Lot 182048, exp 04/30/2020; Lot 183136, exp 06/30/2020; Lot 184217, exp 08/31/2020
- Quantity
- 6,643 cartons
- Company
- American Health Packaging, Columbus, OH
- Distribution
- Nationwide USA
- Initiated
- May 13, 2019 · Voluntary: Firm initiated
- Classified
- June 27, 2019
- Reported
- July 3, 2019
- Ended
- September 30, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pramipexole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.